v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2024   53,428,699      
Beginning balance at Dec. 31, 2024 $ 1,607,860 $ 534 $ 1,240,050 $ 492,640 $ (125,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 24,702     24,702  
Other comprehensive income (loss) 22,975       22,975
Cash dividends declared (7,270)     (7,270)  
Common stock issued in connection with the exercise of stock options and restricted stock awards (in shares)   91,192      
Common stock issued in connection with the exercise of stock options and restricted stock awards (799) $ 1 (800)    
Repurchase of common stock (in shares)   (1,378,962)      
Repurchase of common stock (38,602) $ (14) (38,588)    
Stock-based compensation expense 1,966   1,966    
Ending balance (in shares) at Mar. 31, 2025   52,140,929      
Ending balance at Mar. 31, 2025 1,610,832 $ 521 1,202,628 510,072 (102,389)
Beginning balance (in shares) at Dec. 31, 2025   50,902,024      
Beginning balance at Dec. 31, 2025 1,668,654 $ 509 1,174,894 566,216 (72,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 26,966     26,966  
Other comprehensive income (loss) (16,049)       (16,049)
Cash dividends declared (7,779)     (7,779)  
Common stock issued in connection with the exercise of stock options and restricted stock awards (in shares)   143,853      
Common stock issued in connection with the exercise of stock options and restricted stock awards (1,810) $ 1 (1,811)    
Repurchase of common stock (in shares)   (134,362)      
Repurchase of common stock (4,173) $ (1) (4,172)    
Stock-based compensation expense 1,956   1,956    
Ending balance (in shares) at Mar. 31, 2026   50,911,515      
Ending balance at Mar. 31, 2026 $ 1,667,765 $ 509 $ 1,170,867 $ 585,403 $ (89,014)